Health

"Magic mushroom" treats "modern-day disease"

"magic mushroom" treats "modern-day disease"

NEW YORK (Reuters Health) – A "magic mushroom" can be used to treat depression rather than current drugs, according to a new study.

Dr. Robin Carhart Harris, president of the Center for Anesthesiology Research at Imperial College London, said current depression treatments would be replaced with "magic mushrooms" within five years.

Researchers claim that the salusibin mushroom, which has been studied for several years, can alleviate the symptoms of depression without "weakening" emotions such as what antidepressants do.

Antidepressants contain a list of unwanted side effects that may cause addiction or risk of overdose, so researchers have tried to find a safer drug to use for a long time.

The study is one of the first British experiments to compare silicipin with antidepressants.

In the current trial, about 60 participants with moderate to severe depression receive treatment with silosepin and undergo a treatment session with a clinical psychologist.

Participants will also be randomly assigned to receive alternative medicine or escitalopram to treat depression and anxiety, with no knowledge of researchers or patients who have taken any of the drugs in each group.

Escitalopram is a type of selective serotonin reuptake inhibitor (SSRIs), the largest part of the antidepressant market.

"If you ask people who take selective serotonin reuptake inhibitors, they often say: 'We feel flammable and broken,'" says Harris. "This means that negative and positive emotions are suppressed.

He added: "With the treatment of silicipin, it happens the opposite, where patients talk about emotional release and re-contact, which means that the main emotional center more responsive."

Although the experience seems promising, the treatment is not for everyone, such as those with psychosis.

Evidence from the research team points to the need to combine therapy with "drug trials" to give patients the best alternative to antidepressants.

"If the silosypin mushroom on chronic anti-inflammatory drugs (SSRIs) is effective in its efficacy and popularity, it may have a significant impact on the strength of drugs," Dr. Harris said.

Source: Daily Mail

Tags
Show More

Nawfal Mohammed

Hello I am a student at law college and I am still studying i'M GOOG IN : Blogging, MMA fighter, Designer, Website Management, Bodybuilding, etc BUT my Hobbies :Learn languages, horseback riding, motorcycles and more

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close